![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 18, 2018 4:12:44 PM
Dr. Ian Zagon is an advisor to IMUN/Cytocom and the article is about very important therapeutic potentials for methionine enkephalin (MENK) for which, as you should know, IMUN possesses use patents. OGF (Opioid Growth Factor) is methionine enkephalin.
This article is food for thought and provides just more indication of lost opportunity for IMUN/Cytocom in progressing with the needed clinical studies for which the companies were established. Note on page 249 of article under Financial & Competing Interests Disclosure. Reminder-TNI Biotech Inc. is now IMUN.
Here is the link: www.ncbi.nlm.nih.gov/pubmed/24397732
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM